Category Archives: Cell Therapy

Freeport, The Bahamas (PRWEB) May 20, 2014 Okyanos Heart Institute has announced the addition of Dr. Todd Malan to their executive medical team as Chief Cell Therapy Officer and General Surgeon. He will perform and oversee the liposuction step of Okyanos treatment, removing a small amount of fat from patients from which their own stem cells are isolated. Cardiac cell therapy is intended for no-option heart patients who have exhausted the currently available standards of care for their condition, of which there are about 2 million in the United States alone. Dr. Malan is founder of the Innovative Cosmetic Surgery Center in Scottsdale, Arizona, specializing in advanced liposuction and fat transfer procedures. A pioneer in adipose- (fat) derived stem cell research and fellow of the American Academy of Cosmetic Surgery, Dr. Malan became the first physician in the United States to utilize adult stem cells from fat tissue for soft tissue reconstruction. He has co-authored two medical textbooks on fat-derived stem cell therapies and has served as principal investigator on two Institutional Review Board- (IRB) approved adult stem cell trials. As an active member of the adipose stem cell research community, Dr. Malan is very familiar with the therapeutic benefits … Continue reading →

Stem Cell Therapy using Bone Marrow Derived Mononuclear Cells in Treatment of Lower Limb Lymphedema By: osama ashmawy … Continue reading →

CAR T-Cell Therapy Research: Where Are We Now? There continues to buzz around chimeric antigen receptors (CARs), a potential immunotherapy for the treatment of CLL and also some other conditions. Many patients are excited about the developing... By: Patient Power … Continue reading →

Stem Cell Therapy Saves Eyesight Of Fountain Valley Mother Stem cell therapy saved the eyesight of a Fountain Valley mother. CBS2's Lisa Sigell reports. Official Site: http://losangeles.cbslocal.com/ YouTube: http://... By: CBS Los Angeles … Continue reading →

Enhancing anti cancer adoptive T cell therapy by triggering toll like receptors signaling pathways By: osama ashmawy … Continue reading →

Xuri IL-2 is a dedicated cell therapy ancillary product for the ex vivo cultivation of T-lymphocytes. Xuri IL-2s defined level of biological activity removes the need for revalidation of each lot and strongly improves reproducibility, thereby minimizing process development time and improving scale out capacity. Xuri IL-2 features low endotoxin levels ( … Continue reading →

May 14, 2014, 4 a.m. STEM cell therapy is the great frontier of todays medical research. STEM cell therapy is the great frontier of todays medical research. While still in its infancy, stem cell technology has already moved from being a promising idea to delivering life-saving treatment for conditions such as leukaemia. Last week about 70 people gathered at the Mid City Motel, Warrnambool, to hear about the advances from one of Australias leading researchers. Stem cell researcher, Professor Graham Jenkin. Professor Graham Jenkin, of the department of obstetrics and gynaecology at Monash University, is researching the use of stem cells harvested from umbilical cord blood to treat babies at risk of developing cerebral palsy as the result of oxygen deprivation during birth. The event was hosted by the Warrnambool branch of the Inner Wheel Club as part of a national fund-raising program by the organisation. Professor Jenkin, deputy director of The Ritchie Centre, said treating infants deprived of oxygen with cord blood stem cells was showing promising results in preventing the brain damage that leads to cerebral palsy. We are looking at treating infants within a 24-hour window after birth, Professor Jenkin said. We would be aiming for treatment … Continue reading →

SPRINGFIELD, Mo. -- A child with a life threatening disease is heart wrenching for parents. Suddenly they are faced with no easy way to get a match for stem cells that could save their child. With cell therapy, there is a way to do that but it starts in the delivery room. Delanie Rinne's fourth child, Ezekial, was born earlier this year and even though he'll get older; proof of that day is being stored at Core23 BioBank in Springfield. "We decided to look into banking the cord blood because we know that this is probably our last biological child," says Rinne. Core23 stores your child's blood, plasma or tissue from the umbilical cord to help treat 81 different diseases. "If I had a child that has Leukemia and I was pregnant then that would be a treatment option." Emily and Michael Perry opened the private cord bank as another option for parents. "We see that cell therapy is surpassing bone marrow, we truly believe that it is the medicine of the future." "Cell therapy is taking a healthy, viable cell and putting it into somebody's body to treat a disease or a condition." The process starts in the delivery … Continue reading →

Dr David Gamm on Stem Cell Therapy By: DOCE CANALTV … Continue reading →

Washington, DC (PRWEB) May 05, 2014 There will be a Media Event in Washington, DC, on Wednesday, May 21, 2014, from 10:45 am 12:15 pm in Wilson A of the Marriott Wardman Park Hotel, which is sponsored by the American Society of Gene & Cell Therapy (ASGCT). The event will profile exciting clinical trial results in patients suffering from serious and often fatal diseases such as human immunodeficiency virus (HIV), Inherited Immunodeficiencies, Hemophilia B, and complications from Thrombosis. All registered media will have the opportunity for personal, one-on-one questions with academic and industry leaders in the field, including: Dr. Bruce L. Levine of the University of Pennsylvania is developing a gene and cell therapy strategy to achieve a functional cure for HIV infection by genome editing of cells, and results from the first-in-human trial of this novel treatment strategy will be presented. Professor Adrian Thrasher of the University College of Londons Institute of Child Health will discuss the impressive results of recent advances in gene therapy technology to treat inherited immunodeficiencies in patients, many of whom are children. Researchers at St. Jude Children's Research Hospital have successfully treated Hemophilia patients with gene therapy that led to their disease-free living for … Continue reading →